Trials / Completed
CompletedNCT05534893
Effect of Blueberries on Immunity
Immune Benefits of Blueberry Consumption in Overweight Older Men and Postmenopausal Women: A Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Loma Linda University · Academic / Other
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This research study will test the effects of Blueberries on immune functions in overweight older men and postmenopausal women
Detailed description
This study will examine the effects of Blueberries on clinically relevant markers of immune function. Eligible and selected participants will be randomized to one of two groups at the baseline clinic visit. The Blueberry group participants will consume blueberries (2 packets of blueberry freeze-dried powder equivalent to 2 cups of fresh blueberries) added to the habitual diet and the Control group participants will abstain from blueberries (with instructions to limit the consumption of other berries and polyphenol rich foods) but otherwise continue their habitual diet. During the study, clinic visits will occur at 4-week intervals (baseline, weeks 4, 8 and 12) for a total of 4 visits at the Loma Linda University Nutrition Research Center. Blood samples taken at baseline and at week 12 will be assayed for changes in immune function and inflammatory markers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Blueberry powder group | Participants in the blueberry powder group will receive freeze dried blueberries in form of a powder |
| DIETARY_SUPPLEMENT | Placebo powder group | Participants in the placebo powder group will receive an isocaloric placebo powder |
Timeline
- Start date
- 2022-10-12
- Primary completion
- 2023-09-12
- Completion
- 2023-09-12
- First posted
- 2022-09-10
- Last updated
- 2026-02-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05534893. Inclusion in this directory is not an endorsement.